Glutaric Acidemia I: Clinical Trials

6 trials for Glutaric Acidemia I, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting, 1 unknown. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Recruiting 1

Follow Glutaric Acidemia I: new trials by email Literature Review of Glutaric Acidemia I trials Research Report on Glutaric Acidemia I

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b
VGM-R02b - Glutaric Acidemia Type I, Glutaric Aciduria Type I
Phase 1RecruitingShanghai Vitalgen BioPharma Co., Ltd.122024-04-292026-05-13
Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan
Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days), Obtaining Dry Blood Spots From Healthy Children Aged 8 Days - 7 Years, Obtaining Dry Blood Spots From Healthy Children Aged 8-18 Years - Propionic/Methylmalonic Acidemias, Maple Syrup Urine Disease
UnknownWest Kazakhstan Medical University22502022-10-032023-06-18
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
Evaluation of the Express Plus Range
PKU express plus - Phenylketonurias, PKU
Not applicableCompletedVitaflo International, Ltd282021-06-142026-05-18
Systemic Biomarkers of Brain Injury From Hyperammonemia
Urea Cycle Disorder, Organic Acidemia
RecruitingChildren's National Research Institute242020-07-092024-02-07
Early Check: Expanded Screening in Newborns
Confirmatory Testing - Spinal Muscular Atrophy, Fragile X Syndrome
Active not recruitingRTI International300002018-10-152026-07-01

Narrower conditions

Argininosuccinic Aciduria (4)  ·  Carbamoyl-Phosphate Synthase I Deficiency Disease (4)  ·  Carnitine-Acylcarnitine Translocase Deficiency (4)  ·  Citrullinemia (4)  ·  Homocystinuria (4)  ·  Hyperargininemia (4)  ·  Maple Syrup Urine Disease (4)  ·  Medium chain acyl CoA dehydrogenase deficiency (4)  ·  Ornithine Carbamoyltransferase Deficiency Disease (4)  ·  Trifunctional Protein Deficiency With Myopathy And Neuropathy (4)  ·  Tyrosinemias (4)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (3)  ·  Acidemia, isovaleric (3)  ·  Beta ketothiolase deficiency (3)

Broader conditions

Amino Acid Metabolism, Inborn Errors (5)  ·  Brain Diseases (5)  ·  Brain Diseases, Metabolic (5)  ·  Brain Diseases, Metabolic, Inborn (5)  ·  Central Nervous System Diseases (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Metabolic Diseases (5)  ·  Nervous System Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Connective Tissue Diseases (4)  ·  Genetic Diseases, X-Linked (4)  ·  Hyperhomocysteinemia (4)  ·  Metabolism, Inborn Errors (4)  ·  Mitochondrial Diseases (4)

Interventions

Aging (1)

Sponsors

Centre Hospitalier Universitaire de Liege (1)  ·  Children's National Research Institute (1)  ·  RTI International (1)  ·  Shanghai Vitalgen BioPharma Co., Ltd. (1)  ·  Vitaflo International, Ltd (1)  ·  West Kazakhstan Medical University (1)

Countries

United States (2)  ·  Belgium (1)  ·  China (1)  ·  Kazakhstan (1)  ·  United Kingdom (1)

Top investigators

Anita MacDonald (1)  ·  Curt Scharfe, MD, PhD (1)  ·  Guanping Dong (1)  ·  Gulmira M. Zharmakhanova, MD, PhD (1)  ·  Laurent Servais (1)  ·  Ljubica Caldovic, PhD (1)  ·  Lyazzat M. Syrlybayeva, MD (1)  ·  Nicholas Ah Mew, MD (1)  ·  Qiang Shu (1)  ·  Rulai Yang (1)  ·  Victoria I. Kononets, MD, MS (1)

Results publications

PMID 31315600, PMID 35142618, PMID 38283151

NIH funding

R21TR003166 (1)